CD8A and head and neck squamous cell carcinoma: Compared with TIDE, MIS score, CD8, IFNG, and Merck18, DDX20 alone had a higher AUC (0.62) in head and neck squamous cell carcinoma (Uppaluri2020_PD1_HNSC_Post).